| |
| |
|
| Insider
Information: |
Sherman Michael A. |
| Relationship: |
Director |
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
233,413 |
|
|
Indirect Shares
|
189,995 |
|
|
| Direct
Value |
$221,789 |
|
|
|
Indirect Value
|
$180,533 |
|
|
| Total
Shares |
423,408 |
|
|
| Total
Value |
$402,322 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 65.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
President and CEO, Dir... |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2016-02-26 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Chief Executive Office... |
2023-05-12 |
233,413 |
2023-05-12 |
189,995 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
Director |
2020-12-02 |
0 |
2020-04-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
Chief Financial OfficerOfficer |
• – – |
2011-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
52,356 |
|
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2011-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
19,919 |
72,275 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2011-05-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
19,919 |
73,298 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Chief Financial Officer |
• – – |
2014-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
7,500 |
80,798 |
0 |
- |
|
| ECYT |
Endocyte Inc |
COO and CFO |
• – – |
2015-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,375 |
111,602 |
0 |
- |
|
| ECYT |
Endocyte Inc |
COO and CFO |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
14,375 |
127,437 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2016-02-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,678 |
1,678 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
136,360 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
167,610 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2017-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,373 |
4,051 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
333,111 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President and CEO |
• • – |
2018-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
376,064 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President and CEO |
• • – |
2018-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
84,112 |
379,365 |
0 |
- |
|
| BSTC |
Biospecifics Technologies... |
Director |
– • – |
2020-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,018 |
2,018 |
0 |
- |
|
| BSTC |
Biospecifics Technologies... |
Director |
– • – |
2020-12-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,018) |
0 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Executive Officer |
• • – |
2023-01-17 |
4 |
A |
$0.00 |
$0 |
D/D |
92,950 |
222,995 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-02-06 |
4 |
D |
$2.18 |
$1,509 |
D/D |
(692) |
163,826 |
0 |
- |
|
| ECYT |
Endocyte Inc |
COO and CFO |
• – – |
2016-02-06 |
4 |
D |
$3.02 |
$2,096 |
D/D |
(694) |
124,972 |
0 |
- |
|
| ECYT |
Endocyte Inc |
COO and CFO |
• – – |
2015-02-06 |
4 |
D |
$5.14 |
$3,562 |
D/D |
(693) |
110,909 |
0 |
- |
|
| ECYT |
Endocyte Inc |
COO and CFO |
• – – |
2016-02-04 |
4 |
D |
$3.18 |
$5,632 |
D/D |
(1,771) |
125,666 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-02-04 |
4 |
D |
$2.18 |
$6,741 |
D/D |
(3,092) |
164,518 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President and CEO |
• • – |
2018-02-02 |
4 |
OE |
$3.06 |
$16,686 |
D/D |
5,453 |
338,564 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-05-31 |
4 |
OE |
$2.10 |
$92,999 |
D/D |
44,285 |
208,111 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Chief Executive Officer |
• • – |
2023-05-12 |
4 |
B |
$1.12 |
$97,652 |
I/I |
87,000 |
87,000 |
2.66 |
% |
|
| CMRX |
Chimerix Inc |
Chief Executive Officer |
• • – |
2019-05-20 |
4 |
B |
$3.48 |
$104,316 |
I/I |
30,000 |
30,000 |
2.66 |
- |
|
32 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
